Selexipag Use in Clinical Practice: Mind the Gap

Chest. 2020 Apr;157(4):761-763. doi: 10.1016/j.chest.2019.12.015.

Authors

R James White¹, Daniel J Lachant²

Affiliations

¹ Mary M. Parkes Center and Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center, Rochester, NY. Electronic address: Jim_White@urmc.rochester.edu.
² Mary M. Parkes Center and Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center, Rochester, NY.

PMID: 32252924
DOI: 10.1016/j.chest.2019.12.015

No abstract available

Publication types

Editorial
Comment

MeSH terms

Acetamides
Consensus
Epoprostenol*
Humans
Prostaglandins I
Pulmonary Arterial Hypertension*
Pyrazines

Substances

Acetamides
Prostaglandins I
Pyrazines
selexipag
Epoprostenol